DOCSLIB.ORG

The Vet's Guide To

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Vet's Guide To THE VET’S GUIDE TO ONCOLOGY VOLUME TWO www.sashvets.com VOLUME TWO | CONTENTS 1. Lymphoma 4 2. Mast Cell Tumour 10 3. Soft Tissue Sarcoma 15 4. Osteosarcoma 20 5. Haemangiosarcoma 25 6. Oral Tumours 30 7. Anal Sac Adenocarcinoma 36 8. Client Care 41 CHAPTER ONE LYMPHOMA 3 1. LYMPHOMA DISEASE OVERVIEW In cats lymphoma typically manifests as one of the following: Lymphoma is a cancer that arises from an uncontrolled proliferation of lymphoid cells. As it § Gastrointestinal lymphoma (Gl): this is the is a cancer of a type of white blood cell, lymphoma most common form of feline lymphoma can arise within the lymph nodes or it can arise § Multicentric lymphoma in any site throughout the body. It is the most § Mediastinal lymphoma common cancer in cats and it is observed with § Central nervous system lymphoma relative frequency in dogs. § Ocular lymphoma In some cases, lymphoma may remain localised § Renal lymphoma within the lymphatic system or within its organ of § Nasal lymphoma origin. In most cases, lymphoma is multicentric, resulting in more widespread disease. While location is commonly used to describe lymphoma, there are other classification schemes Usually, the inciting cause of lymphoma is that are also used for both descriptive and unknown. In cats there is a significant correlation prognostic purposes. These characteristics include between the development of lymphoma and tumour staging and tumour grading. infection with FeLV and FIV. Both feline leukaemia virus and feline immunodeficiency virus are Tumour Grade known to contribute to the development of feline lymphoma, although this effect is more pronounced Tumour grade is often used to describe the with feline leukaemia virus. Fortunately, increases expected biologic behaviour of a tumour. in feline vaccination have decreased the incidence of feline leukaemia-associated feline lymphoma In dogs the most common grade of lymphoma and the overall rate of lymphoma diagnosis in is high-grade lymphoma. High-grade lymphoma young cats. is expected to develop more quickly and behave more aggressively than indolent (low-grade) In dogs the most common locations for lymphoma. lymphoma include: In cats the term large cell lymphoma is used to § Multicentric lymphoma: this is the most refer to the equivalent high-grade lymphoma; common form of canine lymphoma, affecting these aggressive lymphoma cells are large and the peripheral lymph nodes and internal organs immature. The term small cell lymphoma is such as the liver, spleen, and bone marrow used to describe low-grade lymphoma, in which § Gastrointestinal (GI) lymphoma: affects the the cells appear indistinguishable from mature stomach and intestines lymphocytes. § Cutaneous lymphoma: affects the epithelial tissues of the oral cavity, skin, nose, and Tumour Staging § Central nervous system (CNS) lymphoma: affects the brain and/or spinal cord Tumour staging describes the extent of spread of a tumour. 4 Lymphoma is staged as follows: The most common location for feline lymphoma § Stage 1: involvement of a single lymph node or is the gastrointestinal tract; therefore, affected single anatomic site cats typically present with GI signs. The most common signs of feline GI lymphoma are anorexia § Stage 2: involvement of lymph nodes on a single and weight loss, although vomiting and diarrhea side of the diaphragm (dogs) or a resectable may also occur. On abdominal palpation, diffuse gastrointestinal tumour with only local lymph intestinal thickening or a palpable abdominal mass node involvement (cats) may be noted; these findings may occur with both § Stage 3: generalized lymph node involvement low-grade and high-grade lymphoma. on both sides of the diaphragm (dogs) or extensive, unresectable abdominal disease Cats with multicentric lymphoma may present (cats) for lethargy, weight loss, anorexia, and other § Stage 4: involvement of the liver and/or spleen nonspecific signs of illness. Mediastinal lymphoma § Stage 5: involvement of the CNS and/or bone may cause respiratory difficulties or shortness marrow or any other organ. of breath. Central nervous system lymphoma may cause neurologic abnormalities or spinal abnormalities, while ocular lymphoma may CLINICAL SIGNS present as visual deficits or blindness. The clinical signs of renal lymphoma are typically identical to The symptoms of lymphoma can vary significantly chronic kidney disease. Nasal lymphoma typically and are largely dependent on the area of the body causes sneezing, nasal discharge, and visible facial that is affected with lymphoid proliferation. swelling. In dogs the most common manifestation DIAGNOSIS of multicentric lymphoma is generalised lymphadenopathy. Owners may notice lumps or Blood Tests and Imaging swellings at the sites of their dog’s lymph nodes, or enlarged lymph nodes may be detected during The workup of a patient presenting to the a veterinary exam. Other non specific clinical veterinarian for nonspecific signs of illness, such signs of multicentric lymphoma include weight as those seen with lymphoma, typically begins loss, lethargy, pale mucous membranes, icterus, with blood tests, including a complete blood count shortness of breath or exercise intolerance, (CBC) and serum biochemistry and urine analysis. increased thirst and urination. In many cases, the CBC of patients with lymphoma Other canine lymphomas will present with is normal. In some patients, however, CBC different medical histories and clinical signs. abnormalities may be observed. Potential CBC Gastrointestinal lymphoma in dogs typically abnormalities in lymphoma patients include: presents as vomiting, diarrhoea, and weight loss. Canine cutaneous lymphoma typically presents § Anaemia, leukopenia, or thrombocytopenia: as a visible lesion on the mucous membrane, or on these abnormalities may be caused by bone the skin, which may be ulcerative or plaque-like in marrow disease or immune-mediated cell appearance. Central nervous system lymphoma destruction may lead to neurologic deficits or spinal pain. § Lymphocytosis: may represent Stage 5 disease or lymphoblastic leukaemia In cats lymphoma very rarely presents as generalised lymphadenopathy. A cat with multiple § Polycythaemia: rarely associated with enlarged lymph nodes may have a different disease renal lymphoma, which results in abnormal process as an underlying cause, such as infection, erythropoietin production or idiopathic lymphadenopathy. § Neutrophilia, eosinophilia, monocytosis: associated with generalised inflammation 5 Serum biochemistry abnormalities are also hyperplasia or inflammation. variable, reflecting the degree of organ involvement. If fine needle aspirate is not diagnostic, biopsy may be required. § Hypercalcaemia: may occur in dogs with T cell lymphoma, associated with paraneoplastic Additional Diagnostics syndrome § Hypoglycaemia: reported in both cats and dogs Additional diagnostics are often recommended to § Hyperglobulinemia: may be associated confirm the diagnosis, provide valuable prognostic with inflammation or monoclonal antibody information, and guide treatment decisions. These production diagnostics include: § Azotaemia: associated with renal lymphoma § Immunocytochemistry: special stains can be § Elevated liver values: associated with hepatic used to distinguish between T cell lymphoma involvement and B cell lymphoma in dogs- and this can be § Panhypoproteinemia: associated with GI done on cytologic samples by Vetnostics lymphoma § Flow cytometry: this test can be used to Imaging in cases of suspected lymphoma may assess for the presence of certain cell markers, include thoracic radiographs and abdominal which may provide information on diagnosis ultrasound to identify extent of disease if needed. and recommended treatment protocols and prognosis Fine Needle Aspirates § Polymerase Chain Reaction Assay for Antigen Receptor Rearrangement (PARR): can help Fine needle aspirates are often taken from distinguish whether an increased lymphoid suspected sites of lymphoma. In the case of canine population is clonal (neoplastic) or is indicative multicentric lymphoma, aspirates can be obtained of inflammation/hyperplasia from multiple lymph nodes to improve diagnostic yield. The mandibular lymph nodes should be TREATMENT avoided, if possible, because oral inflammation can interfere with the ability to obtain an accurate Lymphoma is treated with chemotherapy. Specific diagnosis. In feline gastrointestinal lymphoma, treatment protocols vary depending on tumour ultrasound guidance may permit the aspiration of location, grade, and stage. a thickened region of intestine or an enlarged local lymph node. Canine multicentric lymphoma treatment depends on the results of immunophenotyping. Canine “Under the Microscope” B-cell lymphoma is typically treated with the “CHOP” protocol, which includes a combination of In high-grade or large-cell lymphoma, cytological cyclophosphamide, vincristine, prednisolone and examination of a fine needle aspirate will typically doxorubicin. Canine T-cell lymphoma is typically reveal a population of immature, large lymphocytes treated with the “LOPP” protocol, which includes a with abundant cytoplasm that make up >70% of combination of lomustine, vincristine, procarbazine the cell population.. and prednisolone. In some cases, single agents or smaller combinations of drugs may be used, but In low-grade or small-cell lymphoma, cytology these approaches are typically associated with less typically reveals a uniform population of favourable outcomes. lymphocytes that is relatively normal in Canine
Load more

Recommended publications
  • Heart Tumors in Domestic Animals
    HEART TUMORS IN DOMESTIC ANIMALS Marko Hohšteter Department of veterinary pathology, Veterinary Faculty University of Zagreb Neoplasms of the heart are rare diseases in domestic animals. Among all domestic animals heart neoplasm are most common in dogs. Most of the canine heart tumors are primary what is contrary to other domestic animals, in which most of cardiac tumors are metastatic. Primary tumors of the heart represent 0,69% of the canine tumors. Among all primary neoplasms canine hemangiosarcoma of the right atrium is the most common. Other primary cardiac tumors in domestic animals include rhabdomyoma, rhabdomyosarcoma, myxoma, myxosarcoma, chondrosarcoma, osteosarcoma, granular cell tumor, fibroma, fibrosarcoma, lipoma, pericardial mesothelioma and undifferentiated sarcoma. Aortic and carotid body tumors are usually classified under primary heart neoplasm but are actually tumors which arise in adventitia or periarterial adipose tissue of the aorta, carotid artery or pulmonary artery, and can extend to heart base. Hemangiosarcoma is the most important and most frequent cardiac neoplasm of dogs. This tumor develops primary from the blood vessels that line the heart or can matastasize from sites such as spleen, skin or liver. It is most commonly reported in mid to large breeds, such as boxers, German shepherds, golden retrievers, and in older dogs (six years and older). Aortic and carotide body adenoma and adenocarcinoma belong into the group of chemoreceptor tumors („chemodectomas“) and are morphologicaly similar. In animals, incidence of aortic body neoplasm is higher than that of the carotide body. Both tumors mostly develop in dogs (brachyocephalic breed: boxers, Boston teriers), and are rare in cats and cattle.
    [Show full text]
  • Tumors of the Bone Marrow
    Tumors of the Bone Marrow 803-808-7387 www.gracepets.com These notes are provided to help you understand the diagnosis or possible diagnosis of cancer in your pet. For general information on cancer in pets ask for our handout “What is Cancer”. Your veterinarian may suggest certain tests to help confirm or eliminate diagnosis, and to help assess treatment options and likely outcomes. Because individual situations and responses vary, and because cancers often behave unpredictably, science can only give us a guide. However, information and understanding for tumors in animals is improving all the time. We understand that this can be a very worrying time. We apologize for the need to use some technical language. If you have any questions please do not hesitate to ask us. What is the bone marrow? The bone marrow is the soft tissue inside the bones. Before birth, the marrow contains the primary (stem) cells from which all red and white blood cells will be formed. After birth some types of blood cells, particularly lymphocytes, are made in other parts of the body but the marrow remains the main site for production of circulating blood elements including platelets (which are vital to stop bleeding and make the blood clot), red cells (which carry oxygen) and most white cells (which fight infections and clear up debris). What type of tumors are found in the bone marrow? Tumors of the blood cells made in the marrow are rare. There is a continuum from dysplasias (abnormal growths) to cancers (myeloproliferative disease). Malignant tumors of the blood vessels within the marrow (hemangiosarcomas) are relatively common in dogs although the clinical disease usually shows elsewhere first.
    [Show full text]
  • A Deadly Virus Makes a Comeback
    AnimalNEWS 19.1 A DEADLY VIRUS MAKES A COMEBACK Fur Seals Help Researchers Understand Ocean Life Cancer Research: Looking Back, Moving Forward 2019 Dog & Cat Studies For more than 70 years, Morris Animal YOUR Foundation has been a global leader in funding studies to advance animal American German Shepherd health. With the help of generous GIFTS IN donors like you, we are improving the health and well-being of dogs, cats, Dog Charitable Foundation ACTION horses and wildlife worldwide. PARTNERS IN RESEARCH AND EDUCATION IN THIS ISSUE 2 Your Gifts in Action In 2007, the American German Shepherd Dog Over the years, they have 3 Partners in Research Charitable Foundation Inc. (AGSDCF) made its first gift to support canine health studies at Morris funded research projects in hip 4 Fur Seals Help Researchers dysplasia, genetics of bloat, Animal Foundation. Since then, the organization has canine epilepsy, musculoskeletal 6 It’s More Fun with Goldens continued its investment in research, particularly in conditions and, more recently, 7 Feline Panleukopenia health concerns for the German shepherd. hemangiosarcoma, an almost universally fatal 8 Cancer Research Heart Drug’s Variability cancer in dogs. But this year, they decided to 10 Dog & Cat Health Studies Between 6 and 17 percent of cats with cardiac diseases develop potentially life- invest in veterinary students, While they continue to actively 11 Our New CSO and CDO threatening blood clots. The anticlotting drug clopidogrel, also known as Plavix, is often prescribed to prevent clots from forming. However, veterinarians have been too, and made a gift of fund research, the organization perplexed why some cats respond to treatment and others do not.
    [Show full text]
  • PROPOSED REGULATION of the STATE BOARD of HEALTH LCB File No. R057-16
    PROPOSED REGULATION OF THE STATE BOARD OF HEALTH LCB File No. R057-16 Section 1. Chapter 457 of NAC is hereby amended by adding thereto the following provision: 1. The Division may impose an administrative penalty of $5,000 against any person or organization who is responsible for reporting information on cancer who violates the provisions of NRS 457. 230 and 457.250. 2. The Division shall give notice in the manner set forth in NAC 439.345 before imposing any administrative penalty 3. Any person or organization upon whom the Division imposes an administrative penalty pursuant to this section may appeal the action pursuant to the procedures set forth in NAC 439.300 to 439. 395, inclusive. Section 2. NAC 457.010 is here by amended to read as follows: As used in NAC 457.010 to 457.150, inclusive, unless the context otherwise requires: 1. “Cancer” has the meaning ascribed to it in NRS 457.020. 2. “Division” means the Division of Public and Behavioral Health of the Department of Health and Human Services. 3. “Health care facility” has the meaning ascribed to it in NRS 457.020. 4. “[Malignant neoplasm” means a virulent or potentially virulent tumor, regardless of the tissue of origin. [4] “Medical laboratory” has the meaning ascribed to it in NRS 652.060. 5. “Neoplasm” means a virulent or potentially virulent tumor, regardless of the tissue of origin. 6. “[Physician] Provider of health care” means a [physician] provider of health care licensed pursuant to chapter [630 or 633] 629.031 of NRS. 7. “Registry” means the office in which the Chief Medical Officer conducts the program for reporting information on cancer and maintains records containing that information.
    [Show full text]
  • Partners in Care – January 2017
    The newSEE CE Schedule INSIDE & on a Referralremovable Contact postcard! Info Partners In Care Veterinary Referral News from Angell Animal Medical Center Winter 2017 π Volume 11:1 π angell.org π facebook.com/AngellReferringVeterinarians PRE-HOSPITAL EYELID MARGIN SEDATION OPTIONS BUILDING A RADIOGRAPHIC TUMOR GRADING— MASSES IN DOGS: FOR AGGRESSIVE AND CONFIDENT PUPPY APPROACH TO IS IT APPLICABLE? TO CUT OR ANXIOUS DOGS BONE IMAGING NOT TO CUT? PAGE 1 PAGE 1 PAGE 4 PAGE 6 PAGE 8 ANESTHESIA BEHAVIOR Pre-Hospital Sedation Building a Options for Aggressive Confident Puppy and Anxious Dogs π Terri Bright, Ph.D., BCBA-D, CAAB π Kate Cummings, DVM, DACVAA angell.org/behavior [email protected] angell.org/anesthesia 617-989-1520 [email protected] 617-541-5048 ggressive and/or fearful dogs present several challenges for the othing makes everyone happier than having puppies in the small animal practitioner. These patients are difficult to fully veterinary office. The client brings the pup soon after they evaluate and present a safety hazard to the clinic staff, purchase or adopt it to make sure it is healthy, and to begin the veterinarian, and sometimes even the owner. In addition, a process of vaccinations and a lifetime of health. Everyone oohs Anervous dog contributes to heightened stress within the work area affecting Nand ahs over it, but what are the most important things a vet and their staff not only people, but other pets alike. In dogs known to be aggressive within can do to make sure the pup grows up to be happy and behaviorally healthy? the hospital setting or those with tremendous fear/anxiety, making physical exams and basic assessment impossible, pre-hospital sedation can First, find out what the puppy’s history is.
    [Show full text]
  • Evidenzbericht: S3-Leitlinie „Adulte Weichgewebesarkome“
    Institut für Forschung in der Operativen Medizin (IFOM) Evidenzbericht: S3-Leitlinie „Adulte Weichgewebesarkome“ IFOM - Institut für Forschung in der Operativen Medizin (Universität Witten/Herdecke) Jessica Breuing, Tim Mathes, Katharina Doni, Tanja Rombey, Barbara Prediger, Dawid Pieper Datum: 03.07.2020 Kontakt: Jessica Breuing IFOM - Institut für Forschung in der Operativen Medizin Univ.-Prof. Dr. Rolf Lefering Fakultät für Gesundheit, Department für Humanmedizin Universität Witten/Herdecke Ostmerheimer Str. 200, Haus 38 51109 Köln Tel.: 0221 98957-41 Fax: 0221 98957-30 Dr. Tim Mathes IFOM - Institut für Forschung in der Operativen Medizin Univ.-Prof. Dr. Rolf Lefering Fakultät für Gesundheit, Department für Humanmedizin Universität Witten/Herdecke Ostmerheimer Str. 200, Haus 38 51109 Köln Tel.: 0221 98957-43 Fax: 0221 98957-30 Inhalt 1. Literaturrecherche ........................................................................................................................ 5 1.1. Einschlusskriterien Systemtherapie ....................................................................................... 5 1.1.1. Neoadjuvante Systemtherapie (+ GIST) ........................................................................ 5 1.1.2. Adjuvante Systemtherapie (+ GIST) ............................................................................... 5 1.1.3. Therapie der metastasierten Erkrankung (+ GIST) ...................................................... 6 1.2. Einschlusskriterien Chirurgie ..................................................................................................
    [Show full text]
  • Cat Health Check 2020 No Price
    Feline Health Check Program At Napanee Veterinary Hospital, we are always looking for better tools to help pet owners take care of their pets’ health. This is why we are proud to present our Health Check Program. This program offers health screening that will help us provide the best possible care for your pets. 1. FIV/FeLV Snap Test: -FIV, or Feline Immunodeficiency Virus, is a virus that cats can catch when they go outdoors, especially if they tend to fight with other cats. This virus is similar to the HIV virus in humans. As with humans with HIV, cats with FIV may not show symptoms for many years. There is no cure for FIV, but once we know a cat is infected, we can manage their healthcare accordingly. -FeLV, or Feline Leukemia Virus, is a virus that can cause cancer in cats, as well as immune system deficiencies. Cats can get FeLV, through direct or indirect contact with other cats (for example sharing bowls or grooming). Kittens can also get it from their mom. As with FIV, infected cats may not show symptoms for many years. There is no cure for FeLV, but once we know a cat is infected, we can manage their healthcare accordingly. 2. Early Detection Blood Screening: This test will measure your cat’s blood glucose, as well as specific blood enzymes that give us information on the health and function of the liver and kidneys. Animals that are 7 years or older will also have their thyroid tested and blood cells checked. The goal of this test is to detect subtle anomalies that may not be severe enough to make the animal sick, but allows us to detect early disease and treat them early.
    [Show full text]
  • New Jersey State Cancer Registry List of Reportable Diseases and Conditions Effective Date March 10, 2011; Revised March 2019
    New Jersey State Cancer Registry List of reportable diseases and conditions Effective date March 10, 2011; Revised March 2019 General Rules for Reportability (a) If a diagnosis includes any of the following words, every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report the case to the Department in accordance with the provisions of N.J.A.C. 8:57A. Cancer; Carcinoma; Adenocarcinoma; Carcinoid tumor; Leukemia; Lymphoma; Malignant; and/or Sarcoma (b) Every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report any case having a diagnosis listed at (g) below and which contains any of the following terms in the final diagnosis to the Department in accordance with the provisions of N.J.A.C. 8:57A. Apparent(ly); Appears; Compatible/Compatible with; Consistent with; Favors; Malignant appearing; Most likely; Presumed; Probable; Suspect(ed); Suspicious (for); and/or Typical (of) (c) Basal cell carcinomas and squamous cell carcinomas of the skin are NOT reportable, except when they are diagnosed in the labia, clitoris, vulva, prepuce, penis or scrotum. (d) Carcinoma in situ of the cervix and/or cervical squamous intraepithelial neoplasia III (CIN III) are NOT reportable. (e) Insofar as soft tissue tumors can arise in almost any body site, the primary site of the soft tissue tumor shall also be examined for any questionable neoplasm. NJSCR REPORTABILITY LIST – 2019 1 (f) If any uncertainty regarding the reporting of a particular case exists, the health care facility, physician, dentist, other health care provider or independent clinical laboratory shall contact the Department for guidance at (609) 633‐0500 or view information on the following website http://www.nj.gov/health/ces/njscr.shtml.
    [Show full text]
  • Bone and Soft Tissue Sarcomas
    Bone and Soft Tissue Sarcomas Changes to Pathology Codes in the 4th Edition of the World Health Organisation Classification of Bone and Soft Tissue Sarcomas September 2013 Page 1 of 17 Authors Mr Matthew Francis Cancer Analysis Development Manager, Public Health England Knowledge & Intelligence Team (West Midlands) Dr Nicola Dennis Sarcoma Analyst, Public Health England Knowledge & Intelligence Team (West Midlands) Ms Jackie Charman Cancer Data Development Analyst Public Health England Knowledge & Intelligence Team (West Midlands) Dr Gill Lawrence Breast and Sarcoma Cancer Analysis Specialist, Public Health England Knowledge & Intelligence Team (West Midlands) Professor Rob Grimer Consultant Orthopaedic Oncologist The Royal Orthopaedic Hospital NHS Foundation Trust For any enquiries regarding the information in this report please contact: Mr Matthew Francis Public Health England Knowledge & Intelligence Team (West Midlands) Public Health Building The University of Birmingham Birmingham B15 2TT Tel: 0121 414 7717 Fax: 0121 414 7712 E-mail: [email protected] Acknowledgements The Public Health England Knowledge & Intelligence Team (West Midlands) would like to thank the following people for their valuable contributions to this report: Dr Chas Mangham Consultant Orthopaedic Pathologist, Robert Jones and Agnes Hunt Orthopaedic and District Hospital NHS Trust Professor Nick Athanasou Professor of Musculoskeletal Pathology, University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences Copyright @ PHE Knowledge & Intelligence Team (West Midlands) 2013 1.0 EXECUTIVE SUMMARY Page 2 of 17 The 4th edition of the World Health Organisation (WHO) Classification of Tumours of Soft Tissue and Bone which was published in 2012 contains notable changes from the 2002 3rd edition. The key differences between the 3rd and 4th editions can be seen in Table 1.
    [Show full text]
  • Mammary Gland Tumors in Cats
    Mammary Gland Tumors in Cats (Breast Tumors in Cats) Basics OVERVIEW • Cancerous (malignant) and benign tumors of the breast (mammary glands) in cats • “Mammary” refers to a breast or mammary gland • The mammary glands produce milk to feed newborn kittens; they are located in two rows that extend from the chest to the inguinal area; the nipples indicate the location of the mammary glands • Most cancerous (malignant) breast tumors in cats are carcinomas; benign breast tumors in cats include adenomas, fibroadenomas, and papillomas • Spread to the lungs (known as “pulmonary metastasis”) is seen in up to 80% of cats with breast cancer; spread to the regional lymph nodes is seen in up to 50% of cats GENETICS • The high number of Siamese with breast tumors suggests a genetic component; however, specific genes have not been identified to date SIGNALMENT/DESCRIPTION OF PET Species • Cats; breast (mammary gland) tumors are the third most common type of tumor seen in cats Breed Predilections • Domestic shorthair and longhair cats are affected most commonly, but this likely reflects the popularity of these breeds, rather than a true increased likelihood of developing breast tumors as compared to other cat breeds • Siamese have twice the risk of developing breast tumors than other cat breeds Mean Age and Range • Mean—10–12 years of age • Range—9 months–23 years of age (although most cats are greater than 5 years of age) • Siamese tend to develop breast tumors at a younger age and the incidence begins to plateau around 9 years of age Predominant Sex
    [Show full text]
  • Stem Cell Growth Factor Receptor in Canine Vs. Feline Osteosarcomas
    ONCOLOGY LETTERS 12: 2485-2492, 2016 Stem cell growth factor receptor in canine vs. feline osteosarcomas BIRGITT WOLFESBERGER1, ANDREA FUCHS-BAUMGARTINGER2, JURAJ HLAVATY2, FLORIAN R. MEYER2, MARTIN HOFER3, RALF STEINBORN3, CHRISTIANE GEBHARD2 and INGRID WALTER2 Departments of 1Companion Animals and Horses and 2Pathobiology; 3Genomics Core Facility, VetCore, University of Veterinary Medicine Vienna, A-1210 Vienna, Austria Received April 22, 2015; Accepted July 22, 2016 DOI: 10.3892/ol.2016.5006 Abstract. Osteosarcoma is considered the most common the cats that succumbed to disease earlier was 4 years without bone cancer in cats and dogs, with cats having a much better any adjuvant treatment (3). In cats, metastasis due to osteo- prognosis than dogs, since the great majority of dogs with sarcoma appears to be rare, with an incidence of 5-10% (2-4). osteosarcoma develop distant metastases. In search of a factor By contrast, the median survival times following the amputa- possibly contributing to this disparity, the stem cell growth tion of appendicular osteosarcomas in dogs were 3-5 months, factor receptor KIT was targeted, and the messenger (m)RNA which are relatively low, since dogs rapidly develop metastasis, and protein expression levels of KIT were compared in canine mainly to the lungs, but also to other bones (5-7). By adding vs. feline osteosarcomas, as well as in normal bone. The mRNA adjuvant chemotherapeutics such as carboplatin, cisplatin or expression of KIT was quantified by reverse transcription‑ doxorubicin subsequent to surgery, the median survival time quantitative polymerase chain reaction, and was observed to of dogs was significantly prolonged to ~1 year (8-11).
    [Show full text]
  • Canine Myxosarcomas, a Retrospective Analysis of 32 Dogs (2003–2018) Yoshimi Iwaki1* , Stephanie Lindley1, Annette Smith1, Kaitlin M
    Iwaki et al. BMC Veterinary Research (2019) 15:217 https://doi.org/10.1186/s12917-019-1956-z RESEARCH ARTICLE Open Access Canine myxosarcomas, a retrospective analysis of 32 dogs (2003–2018) Yoshimi Iwaki1* , Stephanie Lindley1, Annette Smith1, Kaitlin M. Curran2 and Jayme Looper3 Abstract Background: Myxosarcomas are known to be classified as soft tissue sarcomas. However, there is limited clinical characterization pertaining specifically to canine cutaneous myxosarcomas in the literature. The objective of this study is to evaluate the local recurrence rate, metastatic rate and prognosis of canine myxosarcoma. Results: A total of 32 dogs diagnosed with myxosarcoma via histopathology were included in this retrospective study. All dogs had surgical resection. No adjunct treatments were performed in 9 dogs, while 22 dogs also received either radiation therapy or chemotherapy, or a combination of both. One dog received only NSAID after surgery. Overall median survival time (MST) was 730 days (range 20–2345 days). The MST of dogs with a tumor mitotic count < 10/10 HPF was 1393 days (range 20–2345 days). The dogs with a tumor mitotic count of 10 or greater/10 HPF had a MST of 433 days (range 169–831 days). There was no significant difference of MST among different treatment modalities. Local recurrence was noted in 13 cases (40.6%) and the median time to recurrence was 115.5 days (range 50–1610 days). The median time to local recurrence in dogs with mitotic count of < 10/10 HPF was 339 days (range 68–1610 days) and in dogs with mitotic count of 10 or greater/10 HPF was 119 days (range 50–378).
    [Show full text]